{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:45:26Z","timestamp":1790541926950,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T00:00:00Z","timestamp":1492992000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature Nanotech"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/nnano.2017.56","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T10:34:19Z","timestamp":1492770859000},"page":"701-710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":161,"title":["Peptide\u2013MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices"],"prefix":"10.1038","volume":"12","author":[{"given":"Santiswarup","family":"Singha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Clemente-Casares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5903-430X","authenticated-orcid":false,"given":"Jes\u00fas","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang Wan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channakeshava Sokke","family":"Umeshappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopa Hebbandi","family":"Nanjundappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2210-5220","authenticated-orcid":false,"given":"Pascal","family":"Detampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Amrein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Fandos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-3682","authenticated-orcid":false,"given":"Robert","family":"Tanguay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Newbigging","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pau","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anmar","family":"Khadra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren C. W.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,24]]},"reference":[{"key":"BFnnano201756_CR1","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.immuni.2010.03.015","volume":"32","author":"S Tsai","year":"2010","unstructured":"Tsai, S. et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 32, 568\u2013580 (2010).","journal-title":"Immunity"},{"key":"BFnnano201756_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature16962","volume":"530","author":"X Clemente-Casares","year":"2016","unstructured":"Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434\u2013440 (2016).","journal-title":"Nature"},{"key":"BFnnano201756_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00109-011-0757-z","volume":"89","author":"X Clemente-Casares","year":"2011","unstructured":"Clemente-Casares, X., Tsai, S., Yang, Y. & Santamaria, P. Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a \u201cone size fits all\u201d approach? J. Mol. Med. 89, 733\u2013742 (2011).","journal-title":"J. Mol. Med."},{"key":"BFnnano201756_CR4","first-page":"509","volume":"9","author":"A McLarnon","year":"2012","unstructured":"McLarnon, A. IBD: regulatory T-cell therapy is a safe and well-tolerated potential approach for treating refractory Crohn's disease. Nat. Rev. Gastroenterol. Hepatol. 9, 509\u2013516 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnnano201756_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1053\/j.gastro.2012.07.116","volume":"143","author":"P Desreumaux","year":"2012","unstructured":"Desreumaux, P. et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 143, 1207\u20131217 (2012).","journal-title":"Gastroenterology"},{"key":"BFnnano201756_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1351\/pac200678051003","volume":"78","author":"J Xie","year":"2006","unstructured":"Xie, J. et al. One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications. Pure Appl. Chem. 78, 1003\u20131014 (2006).","journal-title":"Pure Appl. Chem."},{"key":"BFnnano201756_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/0167-5699(91)90070-A","volume":"12","author":"JM Rojo","year":"1991","unstructured":"Rojo, J. M. & Portoles, P. A symmetrical view of the T-cell receptor-CD3 complex. Immunol. Today 12, 377\u2013378 (1991).","journal-title":"Immunol. Today"},{"key":"BFnnano201756_CR8","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1073\/pnas.96.4.1547","volume":"96","author":"G Fernandez-Miguel","year":"1996","unstructured":"Fernandez-Miguel, G. et al. Multivalent structure of an \u03b1\u03b2T cell receptor. Proc. Natl Acad. Sci. USA 96, 1547\u20131552 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnnano201756_CR9","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/intimm\/dxq443","volume":"22","author":"I Arechaga","year":"2010","unstructured":"Arechaga, I. et al. Structural characterization of the TCR complex by electron microscopy. Int. Immunol. 22, 897\u2013903 (2010).","journal-title":"Int. Immunol."},{"key":"BFnnano201756_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.clim.2004.11.005","volume":"114","author":"KB Scholten","year":"2005","unstructured":"Scholten, K. B. et al. Preservation and redirection of HPV16E7-specific T cell receptors for immunotherapy of cervical cancer. Clin. Immunol. 114, 119\u2013129 (2005).","journal-title":"Clin. Immunol."},{"key":"BFnnano201756_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/imr.12019","volume":"251","author":"WW Schamel","year":"2013","unstructured":"Schamel, W. W. & Alarcon, B. Organization of the resting TCR in nanoscale oligomers. Immunol. Rev. 251, 13\u201320 (2013).","journal-title":"Immunol. Rev."},{"key":"BFnnano201756_CR12","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ni.1832","volume":"11","author":"BF Lillemeier","year":"2010","unstructured":"Lillemeier, B. F. et al. TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation. Nat. Immunol. 11, 90\u201396 (2010).","journal-title":"Nat. Immunol."},{"key":"BFnnano201756_CR13","doi-asserted-by":"publisher","first-page":"e5945","DOI":"10.1371\/journal.pone.0005945","volume":"4","author":"L Zhong","year":"2009","unstructured":"Zhong, L. et al. NSOM\/QD-based direct visualization of CD3-induced and CD28-enhanced nanospatial coclustering of TCR and coreceptor in nanodomains in T cell activation. PLoS ONE 4, e5945 (2009).","journal-title":"PLoS ONE"},{"key":"BFnnano201756_CR14","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ni1272","volume":"6","author":"T Yokosuka","year":"2005","unstructured":"Yokosuka, T. et al. Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat. Immunol. 6, 1253\u20131262 (2005).","journal-title":"Nat. Immunol."},{"key":"BFnnano201756_CR15","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1016\/j.febslet.2010.10.015","volume":"584","author":"K Choudhuri","year":"2010","unstructured":"Choudhuri, K. & Dustin, M. L. Signaling microdomains in T cells. FEBS Lett. 584, 4823\u20134831 (2010).","journal-title":"FEBS Lett."},{"key":"BFnnano201756_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.immuni.2011.10.004","volume":"35","author":"E Sherman","year":"2011","unstructured":"Sherman, E. et al. Functional nanoscale organization of signaling molecules downstream of the T cell antigen receptor. Immunity 35, 705\u2013720 (2011).","journal-title":"Immunity"},{"key":"BFnnano201756_CR17","first-page":"e4105","volume":"66","author":"SB Weisser","year":"2012","unstructured":"Weisser, S. B., van Rooijen, N. & Sly, L. M. Depletion and reconstitution of macrophages in mice. J. Vis. Exp. 66, e4105 (2012).","journal-title":"J. Vis. Exp."},{"key":"BFnnano201756_CR18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nm.3179","volume":"19","author":"N Gagliani","year":"2013","unstructured":"Gagliani, N. et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739\u2013746 (2013).","journal-title":"Nat. Med."},{"key":"BFnnano201756_CR19","first-page":"39","volume":"380","author":"MG Roncarolo","year":"2014","unstructured":"Roncarolo, M. G., Gregori, S., Bacchetta, R. & Battaglia, M. Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr. Top Microbiol. Immunol. 380, 39\u201368 (2014).","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"BFnnano201756_CR20","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.1021\/nn300456z","volume":"6","author":"L Gu","year":"2012","unstructured":"Gu, L., Fang, R. H., Sailor, M. J. & Park, J. H. In vivo clearance and toxicity of monodisperse iron oxide nanocrystals. ACS Nano 6, 4947\u20134954 (2012).","journal-title":"ACS Nano"},{"key":"BFnnano201756_CR21","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1021\/acsnano.5b00042","volume":"9","author":"J Kolosnjaj-Tabi","year":"2015","unstructured":"Kolosnjaj-Tabi, J. et al. The one year fate of iron oxide coated gold nanoparticles in mice. ACS Nano 9, 7925\u20137939 (2015).","journal-title":"ACS Nano"},{"key":"BFnnano201756_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nnano.2013.309","volume":"9","author":"LY Chou","year":"2014","unstructured":"Chou, L. Y., Zagorovsky, K. & Chan, W. C. DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination. Nat. Nanotech. 9, 148\u2013155 (2014).","journal-title":"Nat. Nanotech."},{"key":"BFnnano201756_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis, F., Pridgen, E., Molnar, L. K. & Farokhzad, O. C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505\u2013515 (2008).","journal-title":"Mol. Pharm."},{"key":"BFnnano201756_CR24","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1023\/A:1016010808522","volume":"13","author":"G Borchard","year":"1996","unstructured":"Borchard, G. & Kreuter, J. The role of serum complement on the organ distribution of intravenously administered poly (methyl methacrylate) nanoparticles: effects of pre-coating with plasma and with serum complement. Pharm. Res. 13, 1055\u20131058 (1996).","journal-title":"Pharm. Res."},{"key":"BFnnano201756_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3109\/10611869709017896","volume":"4","author":"TI Armstrong","year":"1997","unstructured":"Armstrong, T. I., Davies, M. C. & Illum, L. Human serum albumin as a probe for protein adsorption to nanoparticles: relevance to biodistribution. J. Drug Target 4, 389\u2013398 (1997).","journal-title":"J. Drug Target"},{"key":"BFnnano201756_CR26","first-page":"4447","volume":"7","author":"F Roohi","year":"2012","unstructured":"Roohi, F., Lohrke, J., Ide, A., Schutz, G. & Dassler, K. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles. Int. J. Nanomed. 7, 4447\u20134458 (2012).","journal-title":"Int. J. Nanomed."},{"key":"BFnnano201756_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/01.rli.0000197669.80475.dd","volume":"41","author":"P Bourrinet","year":"2006","unstructured":"Bourrinet, P. et al. Preclinical safety and pharmacokinetic profile of ferumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest. Radiol. 41, 313\u2013324 (2006).","journal-title":"Invest. Radiol."},{"key":"BFnnano201756_CR28","first-page":"510","volume":"23","author":"P Varallyay","year":"2002","unstructured":"Varallyay, P. et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. AJNR Am. J. Neuroradiol. 23, 510\u2013519 (2002).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnnano201756_CR29","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/026520400417685","volume":"17","author":"N Scholer","year":"2000","unstructured":"Scholer, N. et al. Effect of solid lipid nanoparticles (SLN) on cytokine production and the viability of murine peritoneal macrophages. J. Microencapsul. 17, 639\u2013650 (2000).","journal-title":"J. Microencapsul."},{"key":"BFnnano201756_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0378-5173(01)00882-1","volume":"231","author":"N Scholer","year":"2002","unstructured":"Scholer, N., Hahn, H., Muller, R. H. & Liesenfeld, O. Effect of lipid matrix and size of solid lipid nanoparticles (SLN) on the viability and cytokine production of macrophages. Int. J. Pharm. 231, 167\u2013176 (2002).","journal-title":"Int. J. Pharm."},{"key":"BFnnano201756_CR31","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","volume":"173","author":"T Fifis","year":"2004","unstructured":"Fifis, T. et al. Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors. J. Immunol. 173, 3148\u20133154 (2004).","journal-title":"J. Immunol."},{"key":"BFnnano201756_CR32","doi-asserted-by":"publisher","first-page":"L698","DOI":"10.1152\/ajplung.00084.2005","volume":"2005","author":"AA Shvedova","year":"2005","unstructured":"Shvedova, A. A. et al. Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, L698\u2013L708 (2005).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"BFnnano201756_CR33","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1021\/nl060860z","volume":"6","author":"H Vallhov","year":"2006","unstructured":"Vallhov, H. et al. The importance of an endotoxin-free environment during the production of nanoparticles used in medical applications. Nano Lett. 6, 1682\u20131686 (2006).","journal-title":"Nano Lett."},{"key":"BFnnano201756_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1021\/mp060096p","volume":"4","author":"PL Mottram","year":"2007","unstructured":"Mottram, P. L. et al. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mol. Pharm. 4, 73\u201384 (2007).","journal-title":"Mol. Pharm."},{"key":"BFnnano201756_CR35","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/nature08746","volume":"463","author":"JB Huppa","year":"2010","unstructured":"Huppa, J. B. et al. TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. Nature 463, 963\u2013967 (2010).","journal-title":"Nature"},{"key":"BFnnano201756_CR36","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1083\/jcb.200203043","volume":"158","author":"SC Bunnell","year":"2002","unstructured":"Bunnell, S. C. et al. T cell receptor ligation induces the formation of dynamically regulated signaling assemblies. J. Cell Biol. 158, 1263\u20131275 (2002).","journal-title":"J. Cell Biol."},{"key":"BFnnano201756_CR37","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0092-8674(02)00799-7","volume":"109","author":"D Gil","year":"2002","unstructured":"Gil, D., Schamel, W. W., Montoya, M., Sanchez-Madrid, F. & Alarcon, B. Recruitment of Nck by CD3\u025b reveals a ligand-induced conformational change essential for T cell receptor signaling and synapse formation. Cell 109, 901\u2013912 (2002).","journal-title":"Cell"},{"key":"BFnnano201756_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.immuni.2006.10.019","volume":"26","author":"S Minguet","year":"2007","unstructured":"Minguet, S., Swamy, M., Alarcon, B., Luescher, I. F. & Schamel, W. W. Full activation of the T cell receptor requires both clustering and conformational changes at CD3. Immunity 26, 43\u201354 (2007).","journal-title":"Immunity"},{"key":"BFnnano201756_CR39","doi-asserted-by":"publisher","first-page":"ra43","DOI":"10.1126\/scisignal.2000402","volume":"2","author":"N Martinez-Martin","year":"2009","unstructured":"Martinez-Martin, N. et al. Cooperativity between T cell receptor complexes revealed by conformational mutants of CD3\u025b. Sci. Signal. 2, ra43 (2009).","journal-title":"Sci. Signal."},{"key":"BFnnano201756_CR40","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1073\/pnas.92.11.5042","volume":"92","author":"TW McKeithan","year":"1995","unstructured":"McKeithan, T. W. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl Acad. Sci. USA 92, 5042\u20135046 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnnano201756_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/375148a0","volume":"375","author":"S Valitutti","year":"1995","unstructured":"Valitutti, S., Muller, S., Cella, M., Padovan, E. & Lanzavecchia, A. Serial triggering of many T-cell receptors by a few peptide\u2013MHC complexes. Nature 375, 148\u2013151 (1995).","journal-title":"Nature"},{"key":"BFnnano201756_CR42","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/0092-8674(93)90730-E","volume":"74","author":"JD Katz","year":"1993","unstructured":"Katz, J. D., Wang, B., Haskins, K., Benoist, C. & Mathis, D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089\u20131100 (1993).","journal-title":"Cell"},{"key":"BFnnano201756_CR43","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.186.10.1663","volume":"186","author":"J Verdaguer","year":"1997","unstructured":"Verdaguer, J. et al. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186, 1663\u20131676 (1997).","journal-title":"J. Exp. Med."},{"key":"BFnnano201756_CR44","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1172\/JCI24219","volume":"115","author":"B Han","year":"2005","unstructured":"Han, B. et al. Developmental control of CD8+ T cell-avidity maturation in autoimmune diabetes. J. Clin. Invest. 115, 1879\u20131887 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnnano201756_CR45","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1073\/pnas.89.8.3429","volume":"89","author":"DN Garboczi","year":"1992","unstructured":"Garboczi, D. N., Hung, D. T. & Wiley, D. C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl Acad. Sci. USA 89, 3429\u20133433 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnnano201756_CR46","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1126\/science.274.5284.94","volume":"274","author":"JD Altman","year":"1996","unstructured":"Altman, J. D. et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94\u201396 (1996).","journal-title":"Science"},{"key":"BFnnano201756_CR47","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.4049\/jimmunol.168.7.3145","volume":"168","author":"YY Yu","year":"2002","unstructured":"Yu, Y. Y., Netuschil, N., Lybarger, L., Connolly, J. M. & Hansen, T. H. Cutting edge: single-chain trimers of MHC class I molecules form stable structures that potently stimulate antigen-specific T cells and B cells. J. Immunol. 168, 3145\u20133149 (2002).","journal-title":"J. Immunol."},{"key":"BFnnano201756_CR48","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/nprot.2006.61","volume":"1","author":"J Holst","year":"2006","unstructured":"Holst, J. et al. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1, 406\u2013417 (2006).","journal-title":"Nat. Protoc."},{"key":"BFnnano201756_CR49","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/35021081","volume":"406","author":"A Amrani","year":"2000","unstructured":"Amrani, A. et al. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406, 739\u2013742 (2000).","journal-title":"Nature"},{"key":"BFnnano201756_CR50","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.4049\/jimmunol.165.6.3214","volume":"165","author":"T Stratmann","year":"2000","unstructured":"Stratmann, T. et al. The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J. Immunol. 165, 3214\u20133225 (2000).","journal-title":"J. Immunol."},{"key":"BFnnano201756_CR51","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1021\/nl900031y","volume":"9","author":"SD Perrault","year":"2009","unstructured":"Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C. & Chan, W. C. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett. 9, 1909\u20131915 (2009).","journal-title":"Nano Lett."},{"key":"BFnnano201756_CR52","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1002\/adma.200701975","volume":"19","author":"J Xie","year":"2007","unstructured":"Xie, J., Xu, C., Kohler, N., Hou, Y. & Sun, S. Controlled PEGylation of monodisperse Fe3O4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv. Mater. 19, 3163\u20133166 (2007).","journal-title":"Adv. Mater."},{"key":"BFnnano201756_CR53","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/pi.2251","volume":"56","author":"C Xu","year":"2007","unstructured":"Xu, C. & Sun, S. Monodisperse magnetic nanoparticles for biomedical applications. Polym. Int. 56, 821\u2013826 (2007).","journal-title":"Polym. Int."},{"key":"BFnnano201756_CR54","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1038\/nprot.2011.418","volume":"6","author":"KA Afonin","year":"2011","unstructured":"Afonin, K. A. et al. Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine. Nat. Protoc. 6, 2022\u20132034 (2011).","journal-title":"Nat. Protoc."},{"key":"BFnnano201756_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2217\/nnm.15.196","volume":"11","author":"Y Li","year":"2016","unstructured":"Li, Y. & Boraschi, D. Endotoxin contamination: a key element in the interpretation of nanosafety studies. Nanomedicine 11, 269\u2013287 (2016).","journal-title":"Nanomedicine"},{"key":"BFnnano201756_CR56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/labinvest.3700238","volume":"85","author":"T Nikolic","year":"2005","unstructured":"Nikolic, T., Geutskens, S. B., van Rooijen, N., Drexhage, H. A. & Leenen, P. J. Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab. Invest. 85, 487\u2013501 (2005).","journal-title":"Lab. Invest."},{"key":"BFnnano201756_CR57","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.2353\/ajpath.2006.060539","volume":"169","author":"B Calderon","year":"2006","unstructured":"Calderon, B., Suri, A. & Unanue, E. R. CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet \u03b2-cell killing: studies from an acute model. Am. J. Pathol. 169, 2137\u20132147 (2006).","journal-title":"Am. J. Pathol."},{"key":"BFnnano201756_CR58","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/2211068211432197","volume":"17","author":"D Mandrell","year":"2012","unstructured":"Mandrell, D. et al. Automated zebrafish chorion removal and single embryo placement: optimizing throughput of zebrafish developmental toxicity screens. J. Lab. Autom. 17, 66\u201374 (2012).","journal-title":"J. Lab. Autom."},{"key":"BFnnano201756_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-1-60761-849-2_16","volume":"691","author":"L Truong","year":"2011","unstructured":"Truong, L., Harper, S. L. & Tanguay, R. L. Evaluation of embryotoxicity using the zebrafish model. Methods Mol. Biol. 691, 271\u2013279 (2011).","journal-title":"Methods Mol. Biol."},{"key":"BFnnano201756_CR60","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/toxsci\/kft235","volume":"137","author":"L Truong","year":"2014","unstructured":"Truong, L. et al. Multidimensional in vivo hazard assessment using zebrafish. Toxicol. Sci. 137, 212\u2013233 (2014).","journal-title":"Toxicol. Sci."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nnano.2017.56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nnano.2017.56","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nnano.2017.56","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nnano.2017.56.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:50:26Z","timestamp":1684453826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nnano.2017.56"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,24]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFnnano201756"],"URL":"https:\/\/doi.org\/10.1038\/nnano.2017.56","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,24]]},"assertion":[{"value":"9 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P. Santamaria is scientific founder of Parvus Therapeutics Inc. and has a financial interest in the company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}